Brief: MGC Pharmaceuticals Seeks Trading Halt
30/10/2023 24:52
Oct 30 (Reuters) - MGC Pharmaceuticals Ltd MXC.AX :
* SEEKS TRADING HALT PENDING RELEASE OF AN ANNOUNCEMENT IN
RESPECT
OF A CAPITAL RAISING
Source text for Eikon: ID:nASXVlgPd
Further company coverage: MXC.AX
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Argent BioPharma
See all newsBrief: Argent Biopharma Executes Global Licence For Non-Core Cannabis Genetics
Brief: Argent Biopharma Files Provisional US Patent On Immune Modulation And Longevity
Australia's Argent BioPharma rises to over 1-month high on new licence agreement
Brief: Argent Biopharma Signs NLC Licence To Expand Antiviral Portfolio
Brief: Argent Biopharma Says FDA-CVM Established Inad File For Cannepil Veterinary Program